Bio-based products | Production pathway | Substrat | Nbr reaction step | NAD(P)H yield (mole/mole) | ATP yield (mole/mole) | Pathway yield (Yp)$ | Yield efficiency (%)* |
---|---|---|---|---|---|---|---|
Ethylene glycol (EG) | NP-Dahms | Xylose | 5 | 0 | 0 | 1 | 50 |
Xylulose-1-P | Xylose | 4 | − 1 | − 1 | 0.87 | 50 | |
Ribulose-1-P | Xylose | 5 | − 1 | − 1 | 0.87 | 50 | |
Serine pathway | Glucose | 13 | +2 | 0 | 2 | 83.3 | |
X1P (R1P) + serine pathway | Xylose | 7 | +1 | 0 | 2 | 100 | |
X1P (R1P) + serine pathway | Xylose + glucose | 11 | +2 | 0 | 4 | 91 | |
Glycolic acid (GA) | CCM- (GS)$ | Glucose | 18 | +6 | +2 | 2 | 66 |
NP-Dahms | Xylose | 5 | +2 | 0 | 1 | 40 | |
Xylulose-1-P | Xylose | 4 | +1 | − 1 | 0.96 | 40 | |
Ribulose-1-P | Xylose | 5 | +1 | − 1 | 0.96 | 40 | |
NP-Dahms + GS | Xylose | 10 | +2 (+1QH2) | 0 | 2 | 80 | |
X1P (R1P) + GS | Xylose | 9 | + 3 + (1QH2 | +1 | 2 | 80 | |
X1P (R1P) + GS | Xylose + glucose | 15 | +2 + (3 QH2) | +3 | 4 | 73 | |
1,4 Butanediol (BDO) | CCM$ | Glucose | 21 | 0 | 0 | 1 | 92 |
NP-Weimberg | Xylose | 6 | 0 | 0 | 1 | 110 | |
1,2,4 Butanetriol (BTO) | CCM$ | Glucose | 17 | 0 | -1 | 1 | 83 |
NP-KDC | Xylose | 5 | 0 | 0 | 1 | 100 | |
3,4 dihydroxybutyric acid (3,4-DHBA) | CCM | Glucose | 22 | +3 | 0 | 1 | 66 |
NP-KDC | Xylose | 5 | +2 | 0 | 1 | 80 | |
Mesaconic acid (MSA) | CCM$ | Glucose | 18 | +3 | +1 | 1 | 75 |
NP-Weimberg | Xylose | 8 | +1 | 0 | 1 | 91 | |
Glutaric acid (GTA) | CCM$ | Glucose | 17 | + 5.66 | +1.33 | 1 | Â |
NP-Weimberg + XI | Xylose | 14 | +4 | 0 | 0.66 | 62 |